15alpha-acetoxycleomblynol A - Compound Card

15alpha-acetoxycleomblynol A

Select a section from the left sidebar

15alpha-acetoxycleomblynol A

Structure
Zoomed Structure
  • Family: Plantae - Capparaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Dammarane Triterpenoid
Canonical Smiles CC(=O)O[C@@H]1C[C@@H]2[C@H](C[C@@H]([C@]2([C@]2([C@H]1[C@@]1(C)[C@H](OC(=O)C)CC(=O)OC([C@@H]1CC2)(C)C)C)C)OC(=O)C)[C@]1(C)C=CC(=O)O1
InChI InChI=1S/C33H46O10/c1-17(34)39-22-14-21-20(31(7)13-11-26(37)43-31)15-25(41-19(3)36)33(21,9)30(6)12-10-23-29(4,5)42-27(38)16-24(40-18(2)35)32(23,8)28(22)30/h11,13,20-25,28H,10,12,14-16H2,1-9H3/t20-,21+,22+,23-,24+,25-,28-,30+,31-,32+,33-/m0/s1
InChIKey GOCYQNNXAYOBDN-NANCAXGVSA-N
Formula C33H46O10
HBA 10
HBD 0
MW 602.72
Rotatable Bonds 4
TPSA 131.5
LogP 4.46
Number Rings 5
Number Aromatic Rings 0
Heavy Atom Count 43
Formal Charge 0
Fraction CSP3 0.79
Exact Mass 602.31
Number of Lipinski Rule Violations 1
# Species Family Kingdom NCBI Taxonomy ID
1 Cleome amblyocarpa Capparaceae Plantae 1077932

Showing of synonyms

  • Ahmed AA, Kattab AM, et al. (2001). 15alpha-Acetoxycleomblynol A from Cleome amblyocarpa. Journal of Natural Products,2001,64(1),106-107. [View] [PubMed]
Pubchem: 15511195
Nmrshiftdb2: 70110304

No compound-protein relationship available.

Structure

SMILES: O=C1C=CC(O1)C2CCC(C23)C4C(CC3)C5C(CC4)COC(=O)CC5

Level: 1

Mol. Weight: 602.72 g/mol

Structure

SMILES: C1CCC(C12)CCC3C2CCC4C3CCC(=O)OC4

Level: 0

Mol. Weight: 602.72 g/mol

Structure

SMILES: O=C1C=CCO1

Level: 0

Mol. Weight: 602.72 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-5.12
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-5.02
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Substrate
Skin Permeability
1.6

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
0.66
Plasma Protein Binding
82.69
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Inhibitor
OATP1B3
Inhibitor

Excretion

Clearance
5.18
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-0.37
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.29
Liver Injury II
Toxic
hERG Blockers
Toxic
Daphnia Maga
7.41
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Toxic
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-7256.75
Rat (Acute)
3.99
Rat (Chronic Oral)
1.59
Fathead Minnow
21.27
Respiratory Disease
Safe
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Toxic
SR-p53
Safe

General Properties

Boiling Point
376.13
Hydration Free Energy
-2.91
Log(D) at pH=7.4
2.27
Log(P)
3.05
Log S
-6.01
Log(Vapor Pressure)
-12.2
Melting Point
262.21
pKa Acid
9.15
pKa Basic
3.99

No predicted protein targets found for this compound.

Download SDF